Cargando…
Severe cyclophosphamide-related hyponatremia in a patient with acute glomerulonephritis
Cyclophosphamide is frequently used to treat cancer, autoimmune and renal diseases, such as rapidly progressive glomerulonephritis. Its side effects are well-known, including bone marrow depression, infections, alopecia, sterility, bladder malignancy and hemorrhagic cystitis. Moreover, in some cases...
Autores principales: | Esposito, Pasquale, Domenech, Maria Valentina, Serpieri, Nicoletta, Calatroni, Marta, Massa, Ilaria, Avella, Alessandro, La Porta, Edoardo, Estienne, Luca, Caramella, Elena, Rampino, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500459/ https://www.ncbi.nlm.nih.gov/pubmed/28729970 http://dx.doi.org/10.5527/wjn.v6.i4.217 |
Ejemplares similares
-
Significance of serum Myostatin in hemodialysis patients
por: Esposito, Pasquale, et al.
Publicado: (2019) -
Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
por: Esposito, Pasquale, et al.
Publicado: (2020) -
Low-Dose Cyclophosphamide Associated With Hyponatremia and Hepatotoxicity
por: DeChiara, James R, et al.
Publicado: (2023) -
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities
por: Esposito, Pasquale, et al.
Publicado: (2017) -
Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report
por: Elazzazy, Shereen, et al.
Publicado: (2014)